Compare MSGM & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MSGM | COSM |
|---|---|---|
| Founded | 2018 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Other Pharmaceuticals |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.4M | 13.5M |
| IPO Year | 2020 | 2009 |
| Metric | MSGM | COSM |
|---|---|---|
| Price | $4.48 | $0.35 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 149.6K | ★ 491.1K |
| Earning Date | 06-22-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 252.13 | 45.58 |
| EPS | ★ 1.43 | N/A |
| Revenue | $741,000.00 | ★ $54,426,402.00 |
| Revenue This Year | $69.07 | $20.69 |
| Revenue Next Year | $30.56 | $53.10 |
| P/E Ratio | $3.22 | ★ N/A |
| Revenue Growth | N/A | ★ 1.97 |
| 52 Week Low | $0.73 | $0.28 |
| 52 Week High | $5.78 | $1.32 |
| Indicator | MSGM | COSM |
|---|---|---|
| Relative Strength Index (RSI) | 56.29 | 36.54 |
| Support Level | $2.59 | $0.35 |
| Resistance Level | $4.57 | $0.50 |
| Average True Range (ATR) | 0.53 | 0.03 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 44.12 | 10.45 |
Motorsport Games Inc is a motorsport network company that combines engaging video games with esports competitions and content for racing fans and gamers around the globe. The company has its reportable segments into the development and publishing of interactive racing video games, entertainment content and services, and the organization and facilitation of esports tournaments, competitions, and events for licensed racing games as well as on behalf of third-party video game racing series and other video game publishers. The majority of the revenue is earned from Gaming.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.